Delivery Order HHSN261201500024I-HHSN26100004
Award Date 9/18/17
Potential Completion Date 6/17/20
Potential Value $2.1M
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60616, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $2,398.74 delivery order against the PREVENT Preclinical Drug Development Program indefinite-delivery/indefinite-quantity master contract to IIT Research Institute. IIT Research Institute, a subsidiary of the Illinois Institute Of Technology Sponsored Research And Programs Division, will provide a "CONTRACT ORIENTATION AND KICKOFF MEETING" as the prime contractor. The...
- This is a $718,265.00 delivery order awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to IIT Research Institute, the research and technology development arm of Illinois Institute of Technology (IIT). The contract supports preclinical toxicology and pharmacology research for drugs developed for cancer patients, including exploratory studies of CCR4 CAR T cells. This work is performed under the NCI's "Toxicology of Drugs Developed for...
- This is a $2,561,491.00 delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to the IIT Research Institute, a non-profit research arm of the Illinois Institute of Technology. The contract supports preclinical drug testing services, including pharmacology, toxicology, and safety testing, to generate data for Investigational New Drug applications across therapeutic areas such as cancer, neurology, and...
- This federal contract award is for $2,708.00 to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology (IIT), to provide contract orientation and kickoff meeting services for R&D under the "Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications" program. The contract is being issued by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services. IITRI...
- This federal contract award, valued at $698,236.00, was issued to the Illinois Institute of Technology Research Institute (IITRI), a non-profit organization, by a U.S. government agency. The contract is a Definitive Contract with a Firm Fixed Price pricing type. It does not have a set-aside designation. IITRI is a preclinical contract research organization (CRO) that provides a wide range of services to pharmaceutical, biotechnology, and government clients, including the National Institutes of...
- This federal contract award, valued at $33,483,214.15, was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for preclinical pharmacology and toxicology studies to support the development of small molecule, biologic, and RNA therapeutic candidates across various disease areas. IITRI has extensive experience providing these services to...
- This federal contract award with award ID HHSN261201500024I|HHSN26100003 was issued by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS). The $321,110.80 award was made on September 15, 2016 to the IIT Research Institute (IITRI), a non-profit research organization and division of the Illinois Institute of Technology (IIT). The contract is for the "PRECLINICAL EVALUATION OF A NEW LIPID-BASED SMEDDS" under the NCI's PREVENT...
- The National Cancer Institute awarded a definitive cost-plus-fixed-fee contract to IIT Research Institute (IITRI), a non-profit contract research organization and subsidiary of the Illinois Institute of Technology, for preclinical toxicology and pharmacology services supporting drug development for cancer, AIDS, and AIDS-related illnesses. The contract, awarded on April 1, 2004, carries a ceiling value of $159.3 million with an ultimate completion date of June 30, 2016, and will be performed...
- This is a delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $1,725 firm fixed price order is for a contract orientation meeting and is part of a larger $146.3 million IDIQ contract between IITRI and the National Institute of Allergy and Infectious Diseases (NIAID) for preclinical models of infectious diseases. IITRI has...
- This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI) to IIT Research Institute (IITRI), a non-profit preclinical contract research organization (CRO). The contract is for $532,562.26 to evaluate a breast cancer prevention agent under the PREVENT Cancer Preclinical Drug Development Program, a $149.995 million NCI Indefinite Delivery Vehicle (IDV) that IITRI holds. IITRI has extensive experience providing preclinical drug development services to federal agencies...